VASCULAR RESEARCH NETWORK BVBA (Private limited company)
VASCULAR RESEARCH NETWORK BVBA is a Belgian company registered with the Crossroads Bank for Enterprises under enterprise number 0564.780.124. It was founded on 16-10-2014. Its registered office is in Leuven. Its main activity is: Scientific research and development. Its annual accounts for 2024 report equity of € -158 577 and a loss of € 9 572. These accounts report 0 full-time equivalents. Addrly gives it a financial health grade of B, on a scale from A (safest) to E (most at risk). Its annual accounts for the 2025 financial year have not been filed, although the legal deadline has passed.
Information last updated on 09-10-2026.
Company information
Key figures of VASCULAR RESEARCH NETWORK BVBA
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
Profit / lossiWhat the period earned after taxes. A negative amount is a loss. | € -9 572-6 % | € -9 0180 % | € -9 048 | € 117 |
EquityiWhat belongs to the shareholders: capital contributed, reserves and profits kept in the company. | € -158 577-6 % | € -149 005-6 % | € -139 987-7 % | € -130 939 |
Total assetsiEverything the company owns. Equal to total equity and liabilities, which says how it is financed. | € 45 0690 % | € 45 0690 % | € 44 970-2 % | € 45 686 |
Gross marginiSales and other operating income, minus purchases of goods and services. What is left to pay the staff and everything else. | - | € 0-100 % | € 2-100 % | € 8 373 |
Employees (FTE)iAverage number of workers over the period, in full-time equivalents. | 0 | 0 | - | - |
Financial estimate
Similar companies
Other companies in the same activity in Leuven.
| Company | Town |
|---|---|
| NELSON LABS | 3001 Leuven |
| CUE - GRAPHICS | 3001 Leuven |
| Antleron | 3001 Leuven |
| RAMDESIGN | 3001 Leuven |
| LIMITO | 3001 Leuven |
| BETTER3FRUIT | 3001 Leuven |
| HUAWEI TECHNOLOGIES RESEARCH & DEVELOPMENT BELGIUM | 3001 Leuven |
| reMYND | 3001 Leuven |
Frequently asked questions
Is VASCULAR RESEARCH NETWORK BVBA still active? Yes. The Crossroads Bank for Enterprises lists VASCULAR RESEARCH NETWORK BVBA as active.
What is the VAT number of VASCULAR RESEARCH NETWORK BVBA? VASCULAR RESEARCH NETWORK BVBA is not registered for VAT. Its enterprise number is 0564.780.124.
When was VASCULAR RESEARCH NETWORK BVBA founded? VASCULAR RESEARCH NETWORK BVBA was founded on 16-10-2014.
What is the address of VASCULAR RESEARCH NETWORK BVBA? The current registered office of VASCULAR RESEARCH NETWORK BVBA is Grauwmeer 1, 3001 Louvain.
When did VASCULAR RESEARCH NETWORK BVBA last file annual accounts? The latest annual accounts of VASCULAR RESEARCH NETWORK BVBA were filed on 30-06-2025.
Does VASCULAR RESEARCH NETWORK BVBA file its annual accounts on time? The annual accounts of VASCULAR RESEARCH NETWORK BVBA for the 2025 financial year have not been filed, although the legal deadline has passed.
How many employees does VASCULAR RESEARCH NETWORK BVBA have? VASCULAR RESEARCH NETWORK BVBA employs 0 full-time equivalents according to its most recent annual accounts.
Is VASCULAR RESEARCH NETWORK BVBA financially healthy? Addrly gives VASCULAR RESEARCH NETWORK BVBA a financial health grade of B, on a scale from A (safest) to E (most at risk). The failure probability and the indicators behind it are visible with a free account.
Is VASCULAR RESEARCH NETWORK BVBA profitable? The annual accounts of VASCULAR RESEARCH NETWORK BVBA for 2024 show a loss of € 9 572.
What is the equity of VASCULAR RESEARCH NETWORK BVBA? The equity of VASCULAR RESEARCH NETWORK BVBA was € -158 577 at the close of the 2024 financial year.
Who are the directors of VASCULAR RESEARCH NETWORK BVBA? The annual accounts of VASCULAR RESEARCH NETWORK BVBA record 4 mandates. The names, roles and dates are visible with a free account.
Can VASCULAR RESEARCH NETWORK BVBA receive Peppol e-invoices? Yes. VASCULAR RESEARCH NETWORK BVBA is registered on the Peppol network and can receive structured electronic invoices.
What does VASCULAR RESEARCH NETWORK BVBA do? The main activity of VASCULAR RESEARCH NETWORK BVBA is: Scientific research and development.